Hepatitis D virus (HDV): investigational therapeutic agents in clinical trials.

Published in: Expert opinion on investigational drugs (2021)

This review discusses the clinical impact of HDV infection and offers an in-depth look at the HDV life cycle. The authors examine current and new drug targets and the investigational therapies in clinical trials. The search strategy was based on PubMed database and clinicaltrials.gov which highlight the most up-to-date aspects of investigational therapies for chronic HDV infection.

Keyphrases

drug induced
clinical trial
phase ii
life cycle
adverse drug
open label
optical coherence tomography
phase iii
randomized controlled trial
study protocol
emergency department